Virtus ETF Advisers LLC - 2SEVENTY BIO INC ownership

2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 130 filers reported holding 2SEVENTY BIO INC in Q2 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of 2SEVENTY BIO INC
ValueSharesWeighting
Q3 2023$110,967
-65.7%
28,308
-11.4%
0.07%
-65.1%
Q2 2023$323,486
+26.6%
31,965
+27.6%
0.19%
+36.2%
Q1 2023$255,428
+10.8%
25,042
+1.8%
0.14%
+17.5%
Q4 2022$230,483
+2.9%
24,598
+87.3%
0.12%
+20.0%
Q1 2022$224,000
-33.5%
13,1340.0%0.10%
-21.3%
Q4 2021$337,00013,1340.13%
Other shareholders
2SEVENTY BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Kynam Capital Management, LP 4,890,706$49,493,9456.81%
CHI Advisors LLC 852,007$8,622,3112.62%
Casdin Capital, LLC 2,023,913$20,482,0001.79%
Newtyn Management, LLC 737,744$7,465,9691.76%
Bain Capital Life Sciences Investors, LLC 1,408,901$14,258,0781.47%
DAFNA Capital Management LLC 496,416$5,023,7301.37%
AlphaCentric Advisors LLC 180,000$1,821,6001.01%
SECTORAL ASSET MANAGEMENT INC 462,485$4,680,3480.78%
CLOUGH CAPITAL PARTNERS L P 529,110$5,354,5930.54%
Bleichroeder LP 255,230$2,582,9280.52%
View complete list of 2SEVENTY BIO INC shareholders